Brigette Roberts

Brigette Roberts

Director/Board Member at QUINCE THERAPEUTICS, INC.

Net worth: - $ as of 31/05/2026

Finance
Health Technology
Consumer Services

Profile

Brigette Michelle Roberts is the founder of YYC Capital Management LLC, founded in 2009.
Dr. Roberts is currently Chief Executive Officer & Director at OrphAI Therapeutics, Inc. since 2021.
Dr. Roberts is also Director & Chief Corporate Affairs Officer at Quince Therapeutics, Inc. starting in 2026.
Former positions include Director at Ligand Pharmaceuticals, Inc. from 2005 to 2007, Principal at Third Point Management Co. LLC from 2005 to 2008, Associate at Thomas Weisel Partners LLC from 2001 to 2002, Principal at Nomura Securities International, Inc. in 2012, and Principal at Sturzas Institutional Research, Inc. in 2003.
Education includes an undergraduate degree from Harvard University in 1995 and a doctorate from New York University in 1999.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
18/05/2026 0 ( -.--% ) - $ 31/05/2026

Brigette Roberts active positions

CompaniesPositionStart
QUINCE THERAPEUTICS, INC. Director/Board Member 18/05/2026
Chief Executive Officer -

Former positions of Brigette Roberts

CompaniesPositionEnd
Corporate Officer/Principal 01/12/2012
Founder 01/01/2012
Portfolio Manager-Equities -
LIGAND PHARMACEUTICALS INCORPORATED Director/Board Member 01/03/2007
Corporate Officer/Principal 01/01/2003
See the detail of Brigette Roberts's experience

Training of Brigette Roberts

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Finance

Consumer Services

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Brigette Roberts